The extensive role of PA1 in the modulation of steroid receptor functions, especially in ER, prompted us to investigate its role in clinical breast cancer tissues to explore its correlation with clinicopathological parameters of breast cancer patients. This evidence concerns the gene PAGR1 and breast carcinoma.